Keywords: biovail, revenue, reaches, 936m, canadian, drugmaker, says
Biovail's 2005 revenue reaches $936M
Article | 03 April 2006
Canadian drugmaker Biovail says that it achieved revenues of $936.0 million in the full year 2005, compared with the $879.2 million it recorded ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
